Chemoinformaics analysis of Di-o-methylthujaplicatin methyl ether
| Molecular Weight | 416.47 | nRot | 9 |
| Heavy Atom Molecular Weight | 388.246 | nRig | 18 |
| Exact Molecular Weight | 416.184 | nRing | 3 |
| Solubility: LogS | -4.442 | nHRing | 1 |
| Solubility: LogP | 2.961 | No. of Aliphatic Rings | 1 |
| Acid Count | 0 | No. of Aromatic Rings | 2 |
| Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
| Atoms Count | 58 | No. of Aliphatic Hetero Cycles | 1 |
| No. of Heavy Atom | 30 | No. of Aromatic Carbocycles | 2 |
| nHetero | 7 | No. of Aromatic Hetero Cycles | 0 |
| nBridge Head | 0 | No. Saturated Carbocycles | 0 |
| No. of Hydrogen atom | 28 | No. of Saturated Hetero Cycles | 1 |
| No. of Carbon atom | 23 | No. of Saturated Rings | 1 |
| No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
| No. of Oxygen atom | 7 | No. of Arom Bond | 12 |
| nHA | 7 | APOL | 62.6942 |
| nHD | 0 | BPOL | 39.3738 |
| QED | 0.581 |
| Synth | 3.094 |
| Natural Product Likeliness | 1.091 |
| NR-PPAR-gamma | 0.003 |
| Lipinski | Accepted |
| Pfizer | Accepted |
| GSK | Rejected |
| Golden Triangle | Accepted |
| Pgp-inh | 0.999 |
| Pgp-sub | 0.001 |
| HIA | 0.003 |
| CACO-2 | -4.743 |
| MDCK | 0.0000387 |
| BBB | 0.097 |
| PPB | 0.813948 |
| VDSS | 0.867 |
| FU | 0.115898 |
| CYP1A2-inh | 0.155 |
| CYP1A2-sub | 0.921 |
| CYP2c19-inh | 0.684 |
| CYP2c19-sub | 0.935 |
| CYP2c9-inh | 0.606 |
| CYP2c9-sub | 0.808 |
| CYP2d6-inh | 0.056 |
| CYP2d6-sub | 0.939 |
| CYP3a4-inh | 0.953 |
| CYP3a4-sub | 0.917 |
| CL | 9.879 |
| T12 | 0.766 |
| hERG | 0.287 |
| Ames | 0.088 |
| ROA | 0.018 |
| SkinSen | 0.849 |
| Carcinogencity | 0.051 |
| EI | 0.063 |
| Respiratory | 0.11 |
| NR-Aromatase | 0.635 |
| Antiviral | Yes |
| Prediction | 0.558829 |